Cangrelor (Kengreal)

Indications

Coronary Artery Disease (CAD) (see Coronary Artery Disease, [[Coronary Artery Disease]])

  • Non-ST Elevation Myocardial Infarction (NSTEMI)
  • Post-Percutaneous Coronary Intervention (PCI) (see Percutaneous Coronary Intervention, [[Percutaneous Coronary Intervention]])
  • ST Elevation Myocardial Infarction (STEMI)

Pharmacology

Metabolism

  • xxxx

Administration

  • xxxx

Dose Adjustment

  • Hepatic:
  • Renal:

Adverse Effects

Other Adverse Effects

  • xxx
  • xxx
  • xxx

References

  • xxxx